Global Transdermal Drugs Market: Overview

Transdermal drugs provide improved penetration and control over the toxicity levels; patches can be easily removed in case of high toxicity. Drug permeation can be monitored and estimated more effectively, thereby making it highly efficient in maintaining a constant drug level. The three primary routes of drug penetration are appendageal, transcellular, and intercellular. Major constituents of transdermal drug delivery system are pressure sensitive adhesives, drug, enhancers, polymer matrix, membrane, laminate, and others. Major advantages of transdermal drug delivery are extended therapeutic effect, decrease in drug side effects, improved bioavailability, better patient compliance, and easy termination of drug therapy.

Global Transdermal Drugs Market: Key Trends

The global transdermal drugs market is projected to be driven by increase in the patient population, technological developments in the biopharmaceutical industry, rise in demand for non-invasive drug delivery systems, surge in strategic collaborations between public and private organizations to promote research & development for improved bioavailability of drugs, increase in the geriatric population, rise in self-administration of drugs at home settings, and surge in mergers & acquisitions. However, stringent regulatory guidelines, less awareness in developing countries, and limited availability in smaller economies are expected to restrain the global market.

Global Transdermal Drugs Market: Segmentation

The global transdermal drugs market can be segmented based on product type, application, end-user, and region. In terms of product type, the global market can be bifurcated into transdermal patches and transdermal gels. Based on application, the global transdermal drugs market can be classified into pain management, central nervous system disorders, hormonal applications, cardiovascular diseases, and others such as motion sickness. In terms of end-user, the global market can be divided into hospitals, clinics, home care settings, ambulatory surgical centers, and others.

Global Transdermal Drugs Market: Regional Analysis

In terms of region, the global transdermal drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for major market share during the forecast period, followed by Europe. Presence of major biopharmaceutical companies, high awareness about non-invasive drug delivery, large patient pool, and increase in the number of product launches are attributed to the dominance of the two regions during the forecast period. Asia Pacific is anticipated to present lucrative opportunities for manufacturers in the transdermal drugs market owing to rise in demand for less invasive drug delivery modules, increase in incidence of chronic diseases, rapidly growing geriatric population, surge in health care infrastructure in developing countries such as India, and technological advancements. The transdermal drugs market in Latin America and Middle East & Africa is expected to be driven by adoption of business expansion strategies by major players to increase geographical presence and introduction of favorable regulations by governments to promote research & development.

Global Transdermal Drugs Market: Competitive Landscape

Major players operating in the global transdermal drugs market are Actavis, Inc., Actelion Pharmaceuticals Ltd., 3M Pharmaceuticals, Inc., BioGel Technology, Inc., Johnson & Johnson Limited, Mylan Pharmaceuticals, Inc., Noven Pharmaceuticals, Inc., Novartis AG, Janssen Pharmaceuticals, Inc., GlaxoSmithKline plc, Boehringer Ingelheim GmbH, and Upsher-Smith Laboratories, Inc., among others. Increase in focus of manufacturers on emerging markets, rise in product approvals, and expansion of product portfolio are anticipated to drive the global transdermal drugs market during the forecast period

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Transdermal Drugs Market

Pre Book